超声心动图“顺藤摸出”多浆膜腔积液病因

2017-07-21 朱天刚 超声心动图与临床决策:疑难病例解析

17岁男性,以胸闷起病,发病前无明显不适症状,胸部X线片提示左侧胸腔积液,抗感染及抽胸腔积液治疗效果不佳,并相继出现双侧胸腔积液、心包积液和腹腔积液。超声心动图结果对本病例最终确诊起到重要指导作用。超声心动图对缩窄性心包炎有何诊断价值? 如何与限制型心肌病的超声心动图鉴别?

17岁男性,以胸闷起病,发病前无明显不适症状,胸部X线片提示左侧胸腔积液,抗感染及抽胸腔积液治疗效果不佳,并相继出现双侧胸腔积液、心包积液和腹腔积液。超声心动图结果对本病例最终确诊起到重要指导作用。超声心动图对缩窄性心包炎有何诊断价值? 如何与限制型心肌病的超声心动图鉴别?

病例摘要

主诉

男性,17岁。主因“间断胸闷2个月”入院。

现病史

患者2个月前无明显诱因出现胸闷,无发热,无咳嗽、咳痰、咯血,无呼吸困难,偶感胸痛,吸气时明显,偶伴夜间盗汗。自觉为上呼吸道感染,口服相关药物后症状无缓解,当地县医院X线胸片提示左侧胸腔积液,给予抗感染和胸腔穿刺抽吸胸腔积液治疗效果不佳,并相继出现对侧胸腔积液、心包积液、腹腔积液伴双下肢水肿。为求进一步诊治收入我院呼吸科。

既往史

否认结核、肝炎病史。否认高血压、心脏病、糖尿病史。自诉对 “阿莫西林”过敏。

个人史

出生及生长于河北,学习、生活环境良好。无特殊粉尘、放射线接触史。吸烟史1年,5~6支/日。否认饮酒史。

家族史

父母体健。否认家族遗传性疾病史。

体格检查

体温37.0℃,脉搏100次/分,呼吸18次/分,血压120/90mm Hg。发育正常,营养良好。全身浅表淋巴结未触及肿大。眼睑略水肿。颈静脉充盈,无颈动脉异常搏动。气管居中,甲状腺无肿大。胸廓对称,无畸形。双肺叩诊浊音,双肺呼吸音粗,双下肺呼吸音减弱,未闻及干、湿啰音。心前区无异常隆起或凹陷,心界叩诊不大,心率100次/分,律齐,各瓣膜区未及明显杂音。腹部平坦,肝肋下2指,腹部叩诊鼓音,移动性浊音可疑阳性,肠鸣音4次/分。双下肢无水肿。无杵状指。

辅助检查

血常规、肝功能、肾功能、甲状腺功能正常。自身免疫抗体阴性。胸腔积液检查:胸腔积液介于漏出液、渗出液之间。X线胸片:左侧胸腔积液,心影无异常。胸膜活检病理未见肿瘤。心电图:窦性心动过速,ST-T改变。腹部超声:慢性肝淤血,胆囊壁水肿,双侧胸腔积液,腹腔积液。门诊超声心动图:轻度二尖瓣、三尖瓣反流,微量心包积液。

初步诊断

多浆膜腔积液原因待查,结核性胸膜炎?自身免疫性疾病?恶性胸腔积液?

诊疗经过

根据实验室检查结果,考虑肝源性、肾源性、甲状腺功能减低、自身免疫性疾病以及肿瘤所致多浆膜腔积液病因可基本排除。门诊初次超声心动图未发现可解释多浆膜腔积液的病变,但既往当地医院胸部CT可见心包不规则增厚,因此建议复查超声心动图,以明确有无缩窄性心包炎,确定下一步治疗方案。

入院后,复查超声心动图:①心包不规则增厚、回声增强,以左心室侧壁、左心室后壁、左心室下壁和右心室侧壁处明显,最厚处达8mm(图86-1 A);②室间隔运动异常,吸气时向左心室侧偏移(图86-1A、86-1B);③双心房轻度扩大,左心室壁、右心室壁舒张受限;④二尖瓣舒张期血流频谱E/A>1,E峰速度随呼吸相变化,吸气时下降约32%(图86-1C);⑤下腔静脉增宽,近心段内径约21mm,内径不随呼吸相变化(图86-1D),肺静脉增宽,右上肺静脉入口处内径约10mm(图86-1E);⑥脉冲组织多普勒二尖瓣环室间隔舒张早期速度E'较高,约10cm/s(图86-1F)。结论:考虑缩窄性心包炎可能性大。

依据超声心动图结果,考虑缩窄性心包炎诊断成立。鉴于我国缩窄性心包炎患者的最常见病因为结核感染,征得患者及家属同意后给予诊断性抗结核药物治疗。并请心外科医生会诊,建议转至心外科行手术治疗。患者在全麻下接受心包切除术,术中可见心包不规则增厚 (最厚处约1cm),心包脏层与壁层粘连、纤维化,未见心包腔积液。心包病理学检查:上皮样肉芽肿炎,可见朗格汉斯巨细胞及干酪样坏死,抗酸 (+), PAS(-),考虑结核。术后患者恢复较好,出院继续抗结核药物以及强心、利尿等抗心力衰竭治疗。

最终诊断

缩窄性心包炎,多浆膜腔积液。



图86-1 入院超声心动图 A:心包不规则增厚、回声增强,室间隔吸气时向左心室侧运动 (箭头所示)



B:M型超声心动图显示室间隔运动异常,吸气时室间隔偏移向左心室侧


C:频谱多普勒显示二尖瓣舒张期E峰速度于吸气时下降32%



D:剑下切面显示下腔静脉增宽,内径不随呼吸运动改变



E:显示肺静脉增宽



F:脉冲组织多普勒显示二尖瓣环室间隔舒张早期速度E'约10cm/s。LA:左心房;LV:左心室;RA:右心房;RV:右心室;IVC:下腔静脉

病例思考

1.本例患者的临床特点、超声心动图表现是什么?

本例患者为青年男性,以胸闷起病,发病前无明显不适症状,胸部X线片提示左侧胸腔积液,抗感染及抽胸腔积液治疗效果不佳,并相继出现双侧胸腔积液、心包积液和腹腔积液。实验室检查提示肝功能、肾功能、甲状腺功能正常,自身免疫抗体阴性,胸膜活检未见肿瘤。综合患者病史、辅助检查,临床考虑心包疾病可能性较大。

门诊超声心动图虽无病因学提示,但入院后复查超声心动图显示心包不规则增厚、回声增强,室间隔运动异常,双心房轻度扩大,心脏舒张受限,考虑缩窄性心包炎(constrictive pericarditis,CP)可能性大。超声心动图结果对本病例最终确诊起到重要指导作用。

2.缩窄性心包炎的病理生理机制是什么?

缩窄性心包炎是心包慢性炎症导致心包增厚、粘连、纤维化甚至钙化,使心脏在舒张期充盈受限,引起全身血液循环障碍的疾病。引起缩窄性心包炎的原因包括感染、结缔组织病、肿瘤、机械创伤、心内直视手术或纵隔放疗等,我国患者的最常见病因为结核感染。缩窄性心包炎患者可因心包纤维化、钙化压迫心脏,使各心腔舒张期充盈受限,体循环、肺循环回流受阻,导致舒张期血容量减少、心排出量减低。主要临床症状、体征为严重慢性体循环、肺循环淤血伴低心排出量表现,多数患者并无急性期表现。

3.缩窄性心包炎的诊断方法与确诊依据是什么?

缩窄性心包炎通常起病隐匿,首发表现可涉及多个脏器系统,缺乏特异性,易被临床医生漏诊、误诊或诊断滞后,因此早期确诊一直是临床难题。

心电图无特异性改变,常可见QRS波低电压、ST-T改变和房性心律失常。X线胸片可表现为左右心缘变直、上腔静脉增宽和胸腔积液等征象,偶可见心包钙化。心脏CT与MRI均可准确测量心包厚度。其中,CT对于显示心包增厚、钙化灶具有明显的优势,但不能动态显示心脏舒张受限情况及血流动力学改变。一般观察到心包钙化有助于确诊缩窄性心包炎,但个别病例可能有心包钙化而无心包缩窄的功能改变,因此必须结合临床及其他征象。有创的心导管检查可有特异性表现,即心室舒张期压力曲线呈平方根样,左心室、右心室舒张末期压差≤5mm Hg。无创性超声心动图对缩窄性心包炎诊断具有重要价值。

4.超声心动图对缩窄性心包炎有何诊断价值?

超声心动图是无创、便捷的诊断技术,能够实时、直观显示心包和心脏的形态学改变,多普勒超声心动图可评估心脏血流动力学变化,常规及组织多普勒等新技术能够评价整体、局部心肌功能,因此对诊断与鉴别诊断缩窄性心包炎起着举足轻重的作用,并可为制订治疗策略发挥关键作用。另外,超声心动图还能够鉴别缩窄性心包炎与限制型心肌病,二者临床表现十分相似,但病因、治疗方法和预后完全不同。具体而言,缩窄性心包炎的超声心动图诊断要点包括:

二维、M型超声心动图:①心包增厚、回声增强,尤以房室沟处显着;②心房扩大,心室相对较小;③左心室、右心室舒张受限;④室间隔运动异常,舒张早期反常向左心室内摆动并可立即回弹;⑤下腔静脉、肝静脉和肺静脉增宽,提示体循环、肺循环淤血。

多普勒超声心动图:①心室充盈的呼吸性变化,吸气时二尖瓣E峰流速下降超过25%;②二尖瓣血流频谱表现为“限制型”充盈,E/A>1.5,E峰减速时间<150ms。

5.如何与限制型心肌病的超声心动图鉴别?

限制型心肌病是由于心内膜、心肌病变 (如纤维化)导致心室充盈受限和心室舒张功能障碍的一类心肌病。而缩窄性心包炎的基本病理生理改变是心包压迫心脏,使其充盈受限和心室间依赖性增高,多数患者心肌收缩、舒张功能并无特殊异常。超声心动图除可完成形态学评估外,还能无创评价血流动力学、心肌功能,实现对两种疾病的有效鉴别诊断。主要鉴别要点:限制型心肌病患者的超声心动图一般无明显心包增厚;心房扩大更为显着;无室间隔的异常运动;吸气相二尖瓣E峰流速变化<15%;二尖瓣环E'通常明显减低,E/E'常大于15;肺动脉压增高更明显。

病例启示

遇到有心包积液病史和体循环、肺循环淤血体征的患者,超声心动图医生既应详尽观察心包厚度、回声,尤其房室沟处心包情况,还需仔细观察有无心室充盈受限和心室间依赖性增高变化,如室间隔异常运动,呼吸性漂移,二尖瓣、三尖瓣E峰速度随呼吸变化,下腔静脉、肺静脉扩张等。如有上述典型特征,均提示缩窄性心包炎诊断。超声心动图诊断缩窄性心包炎还需注意以下问题:

1.区别心包增厚与心包缩窄

心包增厚并非一定为缩窄性心包炎,也可见于急性心包炎患者,多因心包膜肿胀、渗出及纤维素附着导致心包增厚,但随着病程好转,渗出液及纤维素吸收后,心包膜可完全恢复正常。另外有部分缩窄性心包炎患者心包厚度正常。鉴别关键是评价心脏是否出现缩窄性心包炎所致的形态学、血流动力学改变。

2.心包缩窄是否为一过性

7%~10%急性心包炎可见一过性缩窄期,因此要注意超声心动图随访。

3.是否为渗液性-缩窄性心包炎

据报道,24%缩窄性心包炎为渗液性-缩窄性心包炎,检查时要注意探查有无心包腔液性无回声区。

4.有何超声心动图线索

超声心动图需尽量为临床医生提供更多诊断信息,包括心包增厚特征、位置,室间隔异常活动,肺静脉、肝静脉血流方向等定性资料,以及最大心包厚度,二尖瓣E/A、E峰减速时间,二尖瓣、三尖瓣血流随呼吸变化程度,E/E'以及下腔静脉内径/塌陷指数等定量数据。

5.超声心动图漏诊原因分析

①忽视临床资料,对缩窄性心包炎缺乏警惕;②对缩窄性心包炎的血流动力学改变、相应超声表现理解欠深刻;③缩窄性心包炎缺乏特异性诊断指标。

来源:《超声心动图与临床决策:疑难病例解析》

作者:朱天刚

参编:丁 茜 权 欣 王 欣 丁文虹 马 为

页码:404-408

出版:人民卫生出版社

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1651014, encodeId=e99516510146f, content=<a href='/topic/show?id=2aa35090181' target=_blank style='color:#2F92EE;'>#心动图#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50901, encryptionId=2aa35090181, topicName=心动图)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7624121693, createdName=zhu_jun9845, createdTime=Wed Dec 20 10:07:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927334, encodeId=2066192e33455, content=<a href='/topic/show?id=f67c6544ef8' target=_blank style='color:#2F92EE;'>#浆膜腔积液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65447, encryptionId=f67c6544ef8, topicName=浆膜腔积液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sat Jan 27 05:07:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225085, encodeId=0380225085ee, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:18 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225084, encodeId=3af322508403, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:14 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224725, encodeId=3c62224e25ff, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:06:45 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224682, encodeId=71c6224682f7, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Jul 21 15:49:55 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224668, encodeId=8f8c224668bd, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/26/c8b491d4a115552789c06a0aff6346a7.jpg, createdBy=f1941967364, createdName=1e14ffd0m25(暂无匿称), createdTime=Fri Jul 21 15:13:09 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1651014, encodeId=e99516510146f, content=<a href='/topic/show?id=2aa35090181' target=_blank style='color:#2F92EE;'>#心动图#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50901, encryptionId=2aa35090181, topicName=心动图)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7624121693, createdName=zhu_jun9845, createdTime=Wed Dec 20 10:07:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927334, encodeId=2066192e33455, content=<a href='/topic/show?id=f67c6544ef8' target=_blank style='color:#2F92EE;'>#浆膜腔积液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65447, encryptionId=f67c6544ef8, topicName=浆膜腔积液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sat Jan 27 05:07:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225085, encodeId=0380225085ee, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:18 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225084, encodeId=3af322508403, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:14 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224725, encodeId=3c62224e25ff, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:06:45 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224682, encodeId=71c6224682f7, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Jul 21 15:49:55 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224668, encodeId=8f8c224668bd, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/26/c8b491d4a115552789c06a0aff6346a7.jpg, createdBy=f1941967364, createdName=1e14ffd0m25(暂无匿称), createdTime=Fri Jul 21 15:13:09 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1651014, encodeId=e99516510146f, content=<a href='/topic/show?id=2aa35090181' target=_blank style='color:#2F92EE;'>#心动图#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50901, encryptionId=2aa35090181, topicName=心动图)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7624121693, createdName=zhu_jun9845, createdTime=Wed Dec 20 10:07:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927334, encodeId=2066192e33455, content=<a href='/topic/show?id=f67c6544ef8' target=_blank style='color:#2F92EE;'>#浆膜腔积液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65447, encryptionId=f67c6544ef8, topicName=浆膜腔积液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sat Jan 27 05:07:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225085, encodeId=0380225085ee, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:18 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225084, encodeId=3af322508403, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:14 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224725, encodeId=3c62224e25ff, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:06:45 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224682, encodeId=71c6224682f7, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Jul 21 15:49:55 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224668, encodeId=8f8c224668bd, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/26/c8b491d4a115552789c06a0aff6346a7.jpg, createdBy=f1941967364, createdName=1e14ffd0m25(暂无匿称), createdTime=Fri Jul 21 15:13:09 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2017-07-22 往日如昨

    学习了谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1651014, encodeId=e99516510146f, content=<a href='/topic/show?id=2aa35090181' target=_blank style='color:#2F92EE;'>#心动图#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50901, encryptionId=2aa35090181, topicName=心动图)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7624121693, createdName=zhu_jun9845, createdTime=Wed Dec 20 10:07:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927334, encodeId=2066192e33455, content=<a href='/topic/show?id=f67c6544ef8' target=_blank style='color:#2F92EE;'>#浆膜腔积液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65447, encryptionId=f67c6544ef8, topicName=浆膜腔积液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sat Jan 27 05:07:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225085, encodeId=0380225085ee, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:18 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225084, encodeId=3af322508403, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:14 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224725, encodeId=3c62224e25ff, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:06:45 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224682, encodeId=71c6224682f7, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Jul 21 15:49:55 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224668, encodeId=8f8c224668bd, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/26/c8b491d4a115552789c06a0aff6346a7.jpg, createdBy=f1941967364, createdName=1e14ffd0m25(暂无匿称), createdTime=Fri Jul 21 15:13:09 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2017-07-22 往日如昨

    学习了谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1651014, encodeId=e99516510146f, content=<a href='/topic/show?id=2aa35090181' target=_blank style='color:#2F92EE;'>#心动图#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50901, encryptionId=2aa35090181, topicName=心动图)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7624121693, createdName=zhu_jun9845, createdTime=Wed Dec 20 10:07:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927334, encodeId=2066192e33455, content=<a href='/topic/show?id=f67c6544ef8' target=_blank style='color:#2F92EE;'>#浆膜腔积液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65447, encryptionId=f67c6544ef8, topicName=浆膜腔积液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sat Jan 27 05:07:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225085, encodeId=0380225085ee, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:18 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225084, encodeId=3af322508403, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:14 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224725, encodeId=3c62224e25ff, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:06:45 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224682, encodeId=71c6224682f7, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Jul 21 15:49:55 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224668, encodeId=8f8c224668bd, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/26/c8b491d4a115552789c06a0aff6346a7.jpg, createdBy=f1941967364, createdName=1e14ffd0m25(暂无匿称), createdTime=Fri Jul 21 15:13:09 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2017-07-21 虈亣靌

    学习了谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1651014, encodeId=e99516510146f, content=<a href='/topic/show?id=2aa35090181' target=_blank style='color:#2F92EE;'>#心动图#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50901, encryptionId=2aa35090181, topicName=心动图)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7624121693, createdName=zhu_jun9845, createdTime=Wed Dec 20 10:07:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927334, encodeId=2066192e33455, content=<a href='/topic/show?id=f67c6544ef8' target=_blank style='color:#2F92EE;'>#浆膜腔积液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65447, encryptionId=f67c6544ef8, topicName=浆膜腔积液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sat Jan 27 05:07:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225085, encodeId=0380225085ee, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:18 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225084, encodeId=3af322508403, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:14 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224725, encodeId=3c62224e25ff, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:06:45 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224682, encodeId=71c6224682f7, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Jul 21 15:49:55 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224668, encodeId=8f8c224668bd, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/26/c8b491d4a115552789c06a0aff6346a7.jpg, createdBy=f1941967364, createdName=1e14ffd0m25(暂无匿称), createdTime=Fri Jul 21 15:13:09 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2017-07-21 hhh678

    henhao

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1651014, encodeId=e99516510146f, content=<a href='/topic/show?id=2aa35090181' target=_blank style='color:#2F92EE;'>#心动图#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50901, encryptionId=2aa35090181, topicName=心动图)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7624121693, createdName=zhu_jun9845, createdTime=Wed Dec 20 10:07:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927334, encodeId=2066192e33455, content=<a href='/topic/show?id=f67c6544ef8' target=_blank style='color:#2F92EE;'>#浆膜腔积液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65447, encryptionId=f67c6544ef8, topicName=浆膜腔积液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sat Jan 27 05:07:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225085, encodeId=0380225085ee, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:18 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225084, encodeId=3af322508403, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jul 22 12:11:14 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224725, encodeId=3c62224e25ff, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:06:45 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224682, encodeId=71c6224682f7, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Jul 21 15:49:55 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224668, encodeId=8f8c224668bd, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/26/c8b491d4a115552789c06a0aff6346a7.jpg, createdBy=f1941967364, createdName=1e14ffd0m25(暂无匿称), createdTime=Fri Jul 21 15:13:09 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2017-07-21 1e14ffd0m25(暂无匿称)

    学习学习

    0

相关资讯

Plos One:浆膜腔积液T-SPOT.TB检测优于外周血

结核性浆膜炎是常见肺外结核的一种,在结核高流行区是形成浆膜腔积液的常见原因之一。既往常用的病原学或组织学阳性是该病诊断的金标准,但存在分枝杆菌培养耗时长、敏感性低等缺点,组织病理学则是有创检查。为找到更理想的诊断方法,北京协和医院感染内科刘晓清、张丽帆、张月秋等以该院2008年至2011年间疑诊为结核性浆膜炎的206例住院病人为对象开展了一项前瞻性的细胞免疫学研究。结果显示,在结核高流行区